News Focus
News Focus
icon url

marjac

03/31/20 12:24 PM

#258925 RE: Bill B #258919

Excellent summary of the legal procedural options moving forward, Bill B.

I understand moving for a new trial to further drag the process out in terms of delaying generic launch, but that will delay filing and disposition of an Appeal by several months, and would have almost no chance of success. So if I was counsel for Amarin, and if the CEO is truly looking out for the shareholders, I would file the Appeal immediately, and forego a futile motion for a new trial.
icon url

Value in the end

03/31/20 12:35 PM

#258930 RE: Bill B #258919

Bill B. Thank you and please update as needed.
icon url

Value in the end

03/31/20 12:35 PM

#258931 RE: Bill B #258919

Bill B. Thank you and please update as needed.
icon url

louieblouie

03/31/20 1:14 PM

#258955 RE: Bill B #258919

icon url

louieblouie

03/31/20 1:15 PM

#258956 RE: Bill B #258919

Question for cmm3 - Can AMRN introduce the reduce-it results before the panel this time?